Search Results 311-320 of 17096 for monoclonal antibody

1. Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

2. Pseudomembranous colitis - Diagnosis & treatment - Mayo Clinic

   The U.S. Food and Drug Administration (FDA) has approved the use of the human monoclonal antibody bezlotoxumab to reduce the risk of recurrence of C.

3. Talquetamab-tgvs (subcutaneous route) - Mayo Clinic

   These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This medicine is available only ...

4. Combination Chemotherapy or 90-Yttrium Ibritumomab Tiuxetan and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Relapsed Diffuse Large B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   Radioactive substances linked to monoclonal antibodies, such as 90-yttrium ibritumomab tiuxetan, can bind to cancer cells and give off radiation which may help ...

5. Trastuzumab-strf (intravenous route) - Mayo Clinic

   Trastuzumab-strf is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...

6. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia - Mayo Clinic

   Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

7. Primary CNS Lymphoma Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as varlilumab and nivolumab, may work by stimulating the immune system to attack cancer tumor cells. A Study to Evaluate the Use ...

8. Osteosarcoma Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as denosumab, may block tumor growth in different ways by targeting certain cells. Sodium Thiosulfate in Preventing Hearing Loss ...

9. Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients with Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma - Mayo Clinic

   RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread ...

10. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...